Gefapixant
ADVERTISEMENT
- Molecular formula
- C23H36N2O
- CAS Number
- 1219908-06-9
- IUPAC Name
- 4-[2-(3-benzyl-3,9-diazabicyclo[3.3.1]nonan-9-yl)-1-methyl-ethyl]morpholine
- Molecular Weight
- 397.57g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.2300g/cm3
Identification
Interesting facts
Exploring 4-[2-(3-benzyl-3,9-diazabicyclo[3.3.1]nonan-9-yl)-1-methyl-ethyl]morpholine
The compound 4-[2-(3-benzyl-3,9-diazabicyclo[3.3.1]nonan-9-yl)-1-methyl-ethyl]morpholine is a fascinating example of a complex organic molecule that exhibits significant potential in medicinal chemistry. Here are some intriguing insights about this compound:
- Structural Uniqueness: The compound contains a morpholine ring, a six-membered ring known for its diverse biological activity. Its presence in pharmaceutical compounds often enhances solubility and modulates pharmacological properties.
- Diverse Applications: Variations of morpholine derivatives are commonly explored as intermediates for drug development, owing to their ability to modulate drug action and improve bioavailability.
- Complex Architecture: The incorporation of the 3-benzyl-3,9-diazabicyclo[3.3.1]nonan-9-yl group adds a layer of complexity, potentially influencing the compound’s interactions with biological targets. The bicyclic structure is known for its stiffness, which may contribute to its biological efficacy.
- Potential Biological Activities: Molecules of this type are often investigated for activities such as antitumor, antiviral, and antidepressant effects, making them of great interest in the pharmaceutical industry.
- Research Interests: Ongoing research efforts focused on the pharmacodynamics and pharmacokinetics of similar compounds may unveil numerous therapeutic possibilities and enhance the understanding of their mechanisms of action.
As a chemistry student or scientist delving into the world of organic compounds, this particular compound serves as a reminder of the intricate relationships between structure and function in drug design. Its study not only furthers our understanding of chemical interactions but also inspires new avenues for therapeutic innovation.